Parry, H M and Pratt, Guy and Hutchison, C A (2012) Monoclonal gammopathy of undetermined significance: an update for nephrologists. Advances in chronic kidney disease, 19 (5). pp. 291-6. ISSN 1548-5609. This article is accessible to all HEFT staff and students via NHS Evidence www.evidence.nhs.uk by using their HEFT Athens login IDsFull text not available from this repository.
Screening for a monoclonal protein is a common part of the assessment of patients presenting with a renal injury. While in the settings of acute kidney injury, chronic kidney disease and proteinuria monoclonal proteins can be associated with significant pathologies such as cast nephropathy, amyloidosis, and light chain deposition disease, they can also be an unrelated finding. The purpose of this review is to provide the nephrologist with an update to the diagnostic assessment and risk stratification of monoclonal proteins to avoid unnecessary investigation and monitoring of those patients with low-risk monoclonal gammopathies.
|Additional Information:||This article is accessible to all HEFT staff and students via NHS Evidence www.evidence.nhs.uk by using their HEFT Athens login IDs|
|Subjects:||WJ Urogenital system. Urology|
|Divisions:||Planned IP Care > Oncology and Clinical Haematology|
|Depositing User:||Mrs Yolande Brookes|
|Date Deposited:||11 Jul 2014 12:22|
|Last Modified:||11 Jul 2014 12:22|
Actions (login required)